XML 43 R33.htm IDEA: XBRL DOCUMENT v3.20.2
Note 2 - Notes Receivable (Details Textual) - USD ($)
May 27, 2020
May 26, 2020
Jun. 30, 2020
Other Capitalized Property Plant and Equipment [Member]      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment, Total $ 1,492,500    
Asset Purchase Agreement with InventaBiotech and Its Subsidiaries, Soluble and BioDeth [Member]      
Stock Issued During Period, Shares, Purchase of Assets (in shares) 125,000    
Other Nonoperating Income $ 1,290,000    
CytoBioscience [Member] | Promissory Notes Receivable [Member]      
Financing Receivable, after Allowance for Credit Loss, Total     $ 1,112,524
Notes Receivable, Interest Rate, Stated Percentage     8.00%
InventaBioTech [Member] | Promissory Note 2017 [Member]      
Nonmonetary Transaction, Gain (Loss) Recognized on Transfer   $ 1,290,000